These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
745 related articles for article (PubMed ID: 7762498)
21. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil]. Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871 [TBL] [Abstract][Full Text] [Related]
22. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647 [TBL] [Abstract][Full Text] [Related]
23. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients. Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597 [TBL] [Abstract][Full Text] [Related]
25. The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia. Tilly-Kiesi M Metabolism; 1991 Jun; 40(6):623-8. PubMed ID: 1865826 [TBL] [Abstract][Full Text] [Related]
26. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM; Barnett MD; Wright JT; Proctor JP Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [TBL] [Abstract][Full Text] [Related]
27. Human serum gangliosides in hypercholesterolemia, before and after extracorporeal elimination of LDL. Senn HJ; Orth M; Fitzke E; Köster W; Wieland H; Gerok W Atherosclerosis; 1992 Jun; 94(2-3):109-17. PubMed ID: 1632864 [TBL] [Abstract][Full Text] [Related]
28. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Alaupovic P; Mack WJ; Knight-Gibson C; Hodis HN Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):715-22. PubMed ID: 9108785 [TBL] [Abstract][Full Text] [Related]
29. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia. Illingworth DR; Bacon S Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064 [TBL] [Abstract][Full Text] [Related]
30. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
31. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine. Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414 [TBL] [Abstract][Full Text] [Related]
33. Management of primary mixed hyperlipidemia with lovastatin. Vega GL; Grundy SM Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864 [TBL] [Abstract][Full Text] [Related]
34. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease. Ford ES; Cooper RS; Simmons B; Castaner A J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048 [TBL] [Abstract][Full Text] [Related]
35. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia. Feussner G; Eichinger M; Ziegler R Clin Investig; 1992 Nov; 70(11):1027-35. PubMed ID: 1472833 [TBL] [Abstract][Full Text] [Related]
36. Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. Groggel GC; Cheung AK; Ellis-Benigni K; Wilson DE Kidney Int; 1989 Aug; 36(2):266-71. PubMed ID: 2779095 [TBL] [Abstract][Full Text] [Related]
37. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027 [TBL] [Abstract][Full Text] [Related]
38. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R; La Belle P; Zupkis R; Ronca P Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032 [TBL] [Abstract][Full Text] [Related]
40. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]